These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 26084127)

  • 1. Impact of CYP2D6 polymorphisms on clinical efficacy and tolerability of metoprolol tartrate.
    Hamadeh IS; Langaee TY; Dwivedi R; Garcia S; Burkley BM; Skaar TC; Chapman AB; Gums JG; Turner ST; Gong Y; Cooper-DeHoff RM; Johnson JA
    Clin Pharmacol Ther; 2014 Aug; 96(2):175-81. PubMed ID: 24637943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on genotype and phenotype of novel CYP2D6 variants using pharmacokinetic and pharmacodynamic models with metoprolol as a substrate drug.
    Qian J; Xu T; Pan P; Sun W; Hu G; Cai J
    Pharmacogenomics J; 2024 Apr; 24(3):13. PubMed ID: 38637522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisoprolol responses (PK/PD) in hypertensive patients: A cytochrome P450 (CYP) 2D6 targeted polymorphism study.
    Mohammed Alkreathy H; Mohammed Eid Alsayyid K; Alaama JY; Al Ghalayini K; Karim S; Esmat A; Damanhouri ZA
    Saudi J Biol Sci; 2020 Oct; 27(10):2727-2732. PubMed ID: 32994732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of CYP2D6
    Zhu Q; Lai W; Li L; Li H; Zhong S
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):328-336. PubMed ID: 31068311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population.
    Mugoša S; Djordjević N; Djukanović N; Protić D; Bukumirić Z; Radosavljević I; Bošković A; Todorović Z
    Patient Prefer Adherence; 2016; 10():1461-9. PubMed ID: 27536078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol.
    Lymperopoulos A; McCrink KA; Brill A
    Curr Drug Metab; 2015; 17(1):30-6. PubMed ID: 26537419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
    Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
    Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol.
    Yuan H; Huang Z; Yang G; Lv H; Sang H; Yao Y
    J Int Med Res; 2008; 36(6):1354-62. PubMed ID: 19094446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
    Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
    Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.
    Thomas CD; Mosley SA; Kim S; Lingineni K; El Rouby N; Langaee TY; Gong Y; Wang D; Schmidt SO; Binkley PF; Estores DS; Feng K; Kim H; Kinjo M; Li Z; Fang L; Chapman AB; Cooper-DeHoff RM; Gums JG; Hamadeh IS; Zhao L; Schmidt S; Frye RF; Johnson JA; Cavallari LH
    CPT Pharmacometrics Syst Pharmacol; 2020 Dec; 9(12):678-685. PubMed ID: 33067866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP 2D6*4 polymorphism and interindividual response variation to metoprolol in stage 1 hypertensive patients: no association in a rural Indian population?
    Ayyappadihas R; Dhanalekshmi U; Jestin H
    Turk J Med Sci; 2015; 45(2):352-7. PubMed ID: 26084127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interactions between metoprolol and antidepressants].
    Molden E; Spigset O
    Tidsskr Nor Laegeforen; 2011 Sep; 131(18):1777-9. PubMed ID: 21946596
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.